US Patent 9340786 RNA interference in dermal and fibrotic indications
Patent 9340786 was granted and assigned to Rxi Pharmaceuticals Corporation on May, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9340786 RNA interference in dermal and fibrotic indications
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.